Payment overview · 2025
General Payments
$328.02
6 reported records · 5 companies
Healthcare provider profile · identity verified
Sandor A Romero, MD
Allopathic & Osteopathic Physicians|Internal Medicine · MIAMI, FL · NPI 1649567421
Verified facts
What the public records show
CMS Open Payments records show Sandor A Romero, MD received $328.02 in general payments during 2025 across 6 reported records.
AstraZeneca Pharmaceuticals LP accounted for 36.6% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 6 associated products.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported BRILINTA as an associated drug or biological on 993 records involving 512 distinct recipient NPIs. Public Medicare Part D data also shows 46 claims for Brilinta by this doctor in 2024.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported FARXIGA as an associated drug or biological on 106133 records involving 42906 distinct recipient NPIs. Public Medicare Part D data also shows 104 claims for Farxiga by this doctor in 2024.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYMBICORT as an associated drug or biological on 71 records involving 51 distinct recipient NPIs. Public Medicare Part D data also shows 20 claims for Symbicort by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | Unresolved — no canonical attribution shown | $119.97 | 36.6% | 1 | 2025 |
| Teva Pharmaceuticals USA, Inc. | Unresolved — no canonical attribution shown | $117.86 | 35.9% | 1 | 2025 |
| Organogenesis Inc. | Unresolved — no canonical attribution shown | $49.90 | 15.2% | 2 | 2025 |
| Baxter Healthcare | Unresolved — no canonical attribution shown | $22.16 | 6.8% | 1 | 2025 |
| Cipher Pharmaceuticals US LLC | Unresolved — no canonical attribution shown | $18.13 | 5.5% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $328.02 | 6 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| LOKELMA Normalized: lokelma |
Drug | AstraZeneca Pharmaceuticals LP | $119.97 | 1 | 2025 |
Source payment records
|
|||||
| AUSTEDO XR Normalized: austedo xr |
Drug | Teva Pharmaceuticals USA, Inc. | $117.86 | 1 | 2025 |
Source payment records
|
|||||
| PURAPLY WOUND MATRIX Normalized: puraply wound matrix |
Device | Organogenesis Inc. | $49.90 | 2 | 2025 |
Source payment records
|
|||||
| Hillrom - Carnation Ambulatory Monitor Normalized: hillrom carnation ambulatory monitor |
Device | Baxter Healthcare | $22.16 | 1 | 2025 |
Source payment records
|
|||||
| Natroba Normalized: natroba |
Drug | Cipher Pharmaceuticals US LLC | $18.13 | 1 | 2025 |
Source payment records
|
|||||
| Spinosad Normalized: spinosad |
Drug | Cipher Pharmaceuticals US LLC | $18.13 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | BRILINTA open payments reported associated product |
CMS Open Payments — General Payments 993 supporting records · 512 recipient NPIs · example record 1206131430 |
Brilinta · 2024 Exact normalized brand match · 1 Part D row |
46 | suppressed by CMS |
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | FARXIGA open payments reported associated product |
CMS Open Payments — General Payments 106133 supporting records · 42906 recipient NPIs · example record 1206131362 |
Farxiga · 2024 Exact normalized brand match · 1 Part D row |
104 | 22 |
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | SYMBICORT open payments reported associated product |
CMS Open Payments — General Payments 71 supporting records · 51 recipient NPIs · example record 1206132610 |
Symbicort · 2024 Exact normalized brand match · 1 Part D row |
20 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Eliquis | Apixaban | 1983 | 281 |
| Atorvastatin Calcium | Atorvastatin Calcium | 1722 | 411 |
| Amlodipine Besylate | Amlodipine Besylate | 1320 | 258 |
| Metoprolol Tartrate | Metoprolol Tartrate | 1229 | 244 |
| Gabapentin | Gabapentin | 1032 | 242 |
| Metformin Hcl | Metformin Hcl | 948 | 177 |
| Losartan Potassium | Losartan Potassium | 884 | 208 |
| Furosemide | Furosemide | 824 | 215 |
| Tamsulosin Hcl | Tamsulosin Hcl | 821 | 165 |
| Lisinopril | Lisinopril | 798 | 167 |
| Levothyroxine Sodium | Levothyroxine Sodium | 789 | 188 |
| Trazodone Hcl | Trazodone Hcl | 745 | 192 |
| Pantoprazole Sodium | Pantoprazole Sodium | 736 | 202 |
| Mirtazapine | Mirtazapine | 734 | 182 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 724 | 159 |
| Clopidogrel | Clopidogrel Bisulfate | 713 | 148 |
| Memantine Hcl | Memantine Hcl | 687 | 131 |
| Carvedilol | Carvedilol | 646 | 140 |
| Quetiapine Fumarate | Quetiapine Fumarate | 597 | 160 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 564 | 184 |
| Donepezil Hcl | Donepezil Hcl | 539 | 110 |
| Levetiracetam | Levetiracetam | 503 | 94 |
| Lactulose | Lactulose | 479 | 102 |
| Hydralazine Hcl | Hydralazine Hcl | 459 | 112 |
| Escitalopram Oxalate | Escitalopram Oxalate | 448 | 115 |
| Famotidine | Famotidine | 438 | 128 |
| Montelukast Sodium | Montelukast Sodium | 435 | 84 |
| Metoprolol Succinate | Metoprolol Succinate | 395 | 107 |
| Latanoprost | Latanoprost | 386 | 80 |
| Divalproex Sodium | Divalproex Sodium | 378 | 83 |
| Simvastatin | Simvastatin | 357 | 68 |
| Baclofen | Baclofen | 317 | 74 |
| Sertraline Hcl | Sertraline Hcl | 314 | 88 |
| Nifedipine Er | Nifedipine | 299 | 81 |
| Finasteride | Finasteride | 298 | 61 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 289 | 54 |
| Potassium Chloride | Potassium Chloride | 270 | 72 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 260 | 46 |
| Ketoconazole | Ketoconazole | 260 | 110 |
| Glipizide | Glipizide | 254 | 59 |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 245 | 51 |
| Xarelto | Rivaroxaban | 241 | 39 |
| Risperidone | Risperidone | 220 | 59 |
| Omeprazole | Omeprazole | 218 | 70 |
| Clonidine Hcl | Clonidine Hcl | 204 | 70 |
| Hydrochlorothiazide | Hydrochlorothiazide | 204 | 60 |
| Citalopram Hbr | Citalopram Hydrobromide | 195 | 51 |
| Spironolactone | Spironolactone | 191 | 47 |
| Jardiance | Empagliflozin | 184 | 15 |
| Entresto | Sacubitril/Valsartan | 182 | 36 |
| Novolog Flexpen | Insulin Aspart | 181 | 51 |
| Allopurinol | Allopurinol | 179 | 38 |
| Budesonide | Budesonide | 179 | 50 |
| Levofloxacin | Levofloxacin | 177 | 117 |
| Midodrine Hcl | Midodrine Hcl | 175 | 73 |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 165 | 61 |
| Fiasp Flextouch | Insulin Aspart (Niacinamide) | 164 | 38 |
| Januvia | Sitagliptin Phosphate | 163 | 20 |
| Duloxetine Hcl | Duloxetine Hcl | 157 | 36 |
| Azithromycin | Azithromycin | 154 | 83 |
| Humalog Kwikpen U-100 | Insulin Lispro | 152 | 35 |
| Mupirocin | Mupirocin | 150 | 97 |
| Brimonidine Tartrate | Brimonidine Tartrate | 149 | 21 |
| Amiodarone Hcl | Amiodarone Hcl | 147 | 50 |
| Ingrezza | Valbenazine Tosylate | 140 | 21 |
| Procrit | Epoetin Alfa | 140 | 29 |
| Buspirone Hcl | Buspirone Hcl | 138 | 48 |
| Sodium Chloride | 0.9 % Sodium Chloride | 137 | 64 |
| Sucralfate | Sucralfate | 133 | 28 |
| Nystatin | Nystatin | 132 | 71 |
| Novolin R | Insulin Regular, Human | 128 | 33 |
| Ondansetron Hcl | Ondansetron Hcl | 127 | 53 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 125 | 69 |
| Bumetanide | Bumetanide | 119 | 33 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 117 | 58 |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 111 | 31 |
| Ceftriaxone | Ceftriaxone Sodium | 108 | 49 |
| Megestrol Acetate | Megestrol Acetate | 106 | 56 |
| Humulin R | Insulin Regular, Human | 105 | 38 |
| Farxiga | Dapagliflozin Propanediol | 104 | 22 |
| Benztropine Mesylate | Benztropine Mesylate | 101 | 30 |
| Doxazosin Mesylate | Doxazosin Mesylate | 100 | 25 |
| Gemtesa | Vibegron | 99 | suppressed |
| Prednisone | Prednisone | 97 | 52 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 96 | 22 |
| Meloxicam | Meloxicam | 95 | 28 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 93 | 34 |
| Glimepiride | Glimepiride | 91 | 12 |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 89 | 24 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 88 | 23 |
| Folic Acid | Folic Acid | 87 | 59 |
| Doxycycline Hyclate | Doxycycline Hyclate | 84 | 47 |
| Piperacillin-Tazobactam | Piperacillin Sodium/Tazobactam | 84 | 39 |
| Sevelamer Carbonate | Sevelamer Carbonate | 83 | 26 |
| Hydrocortisone | Hydrocortisone | 82 | 35 |
| Meropenem | Meropenem | 82 | 25 |
| Novolin R Flexpen | Insulin Regular, Human | 82 | 24 |
| Olanzapine | Olanzapine | 81 | 27 |
| Albuterol Sulfate | Albuterol Sulfate | 80 | 29 |
| Digoxin | Digoxin | 80 | 18 |
| Paroxetine Hcl | Paroxetine Hcl | 78 | 17 |
| Atenolol | Atenolol | 77 | 19 |
| Fluticasone Propionate | Fluticasone Propionate | 77 | 31 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 77 | 29 |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 76 | 15 |
| Fluoxetine Hcl | Fluoxetine Hcl | 76 | 24 |
| Nuplazid | Pimavanserin Tartrate | 75 | suppressed |
| Haloperidol | Haloperidol | 74 | 20 |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 74 | 15 |
| Diltiazem Hcl | Diltiazem Hcl | 72 | 16 |
| Timolol Maleate | Timolol Maleate | 70 | 18 |
| Methylprednisolone | Methylprednisolone | 69 | 39 |
| Ipratropium Bromide | Ipratropium Bromide | 68 | 28 |
| Clobetasol Propionate | Clobetasol Propionate | 65 | 26 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 62 | 29 |
| Celecoxib | Celecoxib | 62 | 13 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 61 | 41 |
| Labetalol Hcl | Labetalol Hcl | 61 | 17 |
| Silver Sulfadiazine | Silver Sulfadiazine | 61 | 28 |
| Fenofibrate | Fenofibrate Nanocrystallized | 59 | 13 |
| Trulicity | Dulaglutide | 59 | 12 |
| Anastrozole | Anastrozole | 57 | suppressed |
| Ibuprofen | Ibuprofen | 57 | 25 |
| Retacrit | Epoetin Alfa-Epbx | 57 | 15 |
| Novolog | Insulin Aspart | 56 | 12 |
| Tradjenta | Linagliptin | 56 | suppressed |
| Insulin Lispro | Insulin Lispro | 54 | 20 |
| Cyproheptadine Hcl | Cyproheptadine Hcl | 52 | 38 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 52 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 51 | 20 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 50 | 31 |
| Meclizine Hcl | Meclizine Hcl | 50 | suppressed |
| Methocarbamol | Methocarbamol | 50 | 21 |
| Nyamyc | Nystatin | 50 | 23 |
| Valsartan | Valsartan | 50 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 49 | suppressed |
| Solu-Medrol | Methylprednisolone Sod Succ/Pf | 49 | 28 |
| Candesartan Cilexetil | Candesartan Cilexetil | 48 | suppressed |
| Santyl | Collagenase Clostridium Hist. | 47 | 31 |
| Brilinta | Ticagrelor | 46 | suppressed |
| Glipizide Er | Glipizide | 46 | 11 |
| Amantadine | Amantadine Hcl | 45 | 13 |
| Amoxicillin | Amoxicillin | 45 | 26 |
| Pioglitazone Hcl | Pioglitazone Hcl | 45 | 13 |
| Fiasp | Insulin Aspart (Niacinamide) | 44 | 18 |
| Oxcarbazepine | Oxcarbazepine | 44 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 44 | 13 |
| Admelog Solostar | Insulin Lispro | 41 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 41 | 12 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 41 | 20 |
| Irbesartan | Irbesartan | 41 | suppressed |
| Prednisolone Acetate | Prednisolone Acetate | 41 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 41 | 13 |
| Dapagliflozin | Dapagliflozin Propanediol | 40 | 23 |
| Fluconazole | Fluconazole | 40 | 25 |
| Diclofenac Sodium | Diclofenac Sodium | 38 | 14 |
| Dorzolamide Hcl | Dorzolamide Hcl | 38 | suppressed |
| Insulin Aspart Flexpen | Insulin Aspart | 38 | 16 |
| Fenofibrate | Fenofibrate | 37 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 37 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 37 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 36 | suppressed |
| Paricalcitol | Paricalcitol | 36 | suppressed |
| Cefepime Hcl | Cefepime Hcl | 35 | 17 |
| Cilostazol | Cilostazol | 35 | suppressed |
| Glucagon Emergency Kit | Glucagon | 35 | 13 |
| Lansoprazole | Lansoprazole | 35 | suppressed |
| Aripiprazole | Aripiprazole | 34 | 17 |
| Enoxaparin Sodium | Enoxaparin Sodium | 34 | 20 |
| Scopolamine | Scopolamine | 34 | suppressed |
| Tivicay | Dolutegravir Sodium | 34 | suppressed |
| Calcitriol | Calcitriol | 33 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 33 | suppressed |
| Topiramate | Topiramate | 33 | suppressed |
| Gentamicin Sulfate | Gentamicin Sulfate | 32 | 20 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 32 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl/Pf | 32 | 21 |
| Oxybutynin Chloride | Oxybutynin Chloride | 32 | suppressed |
| Pentoxifylline | Pentoxifylline | 32 | suppressed |
| Cephalexin | Cephalexin | 30 | 24 |
| Biktarvy | Bictegrav/Emtricit/Tenofov Ala | 29 | suppressed |
| Valproic Acid | Valproic Acid | 29 | suppressed |
| Epogen | Epoetin Alfa | 28 | suppressed |
| Telmisartan | Telmisartan | 28 | suppressed |
| Humalog | Insulin Lispro | 26 | 11 |
| Nitroglycerin | Nitroglycerin | 26 | 14 |
| Rexulti | Brexpiprazole | 26 | suppressed |
| Vancomycin Hcl | Vancomycin Hcl | 26 | 12 |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 25 | suppressed |
| Sevelamer Hcl | Sevelamer Hcl | 25 | suppressed |
| Ssd | Silver Sulfadiazine | 25 | 14 |
| Torsemide | Torsemide | 25 | suppressed |
| Acyclovir | Acyclovir | 24 | 14 |
| Divalproex Sodium Er | Divalproex Sodium | 23 | suppressed |
| Lorazepam | Lorazepam | 23 | 12 |
| Naproxen | Naproxen | 23 | suppressed |
| Clonazepam | Clonazepam | 22 | 13 |
| Colchicine | Colchicine | 22 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 22 | suppressed |
| Heparin Sodium | Heparin Sodium,porcine | 22 | suppressed |
| Metronidazole | Metronidazole | 22 | 14 |
| Neomycin-Polymyxin-Dexameth | Neomycin/Polymyxin B/Dexametha | 22 | 16 |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 22 | 16 |
| Calcium Acetate | Calcium Acetate | 21 | suppressed |
| Enulose | Lactulose | 21 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 21 | suppressed |
| Lamotrigine | Lamotrigine | 21 | suppressed |
| Mesalamine | Mesalamine | 21 | suppressed |
| Primidone | Primidone | 21 | suppressed |
| Varenicline Tartrate | Varenicline Tartrate | 21 | suppressed |
| Cefdinir | Cefdinir | 20 | 16 |
| Ciclopirox | Ciclopirox | 20 | 13 |
| Ertapenem | Ertapenem Sodium | 20 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 20 | suppressed |
| Lacosamide | Lacosamide | 20 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 20 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 20 | 15 |
| Symbicort | Budesonide/Formoterol Fumarate | 20 | suppressed |
| Temazepam | Temazepam | 20 | 14 |
| Venlafaxine Hcl | Venlafaxine Hcl | 20 | suppressed |
| Bicalutamide | Bicalutamide | 19 | suppressed |
| Lidocaine | Lidocaine | 19 | suppressed |
| Vancomycin Hcl | Vancomycin/Water For Inj (Peg) | 19 | suppressed |
| Acetylcysteine | Acetylcysteine | 18 | suppressed |
| Entacapone | Entacapone | 18 | suppressed |
| Ofloxacin | Ofloxacin | 18 | suppressed |
| Saxagliptin Hcl | Saxagliptin Hcl | 18 | suppressed |
| Bethanechol Chloride | Bethanechol Chloride | 17 | suppressed |
| Carbamazepine | Carbamazepine | 17 | suppressed |
| Mometasone Furoate | Mometasone Furoate | 17 | 12 |
| Descovy | Emtricitabine/Tenofov Alafenam | 16 | suppressed |
| Haloperidol Lactate | Haloperidol Lactate | 16 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 16 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 16 | suppressed |
| Tobramycin | Tobramycin | 16 | suppressed |
| Alphagan P | Brimonidine Tartrate | 15 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 15 | suppressed |
| Lamivudine | Lamivudine | 15 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 15 | suppressed |
| Lyumjev Kwikpen U-100 | Insulin Lispro-Aabc | 15 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 15 | suppressed |
| Ranolazine Er | Ranolazine | 15 | suppressed |
| Silodosin | Silodosin | 15 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 15 | 11 |
| Amiloride Hcl | Amiloride Hcl | 14 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 14 | suppressed |
| Indapamide | Indapamide | 14 | suppressed |
| Nadolol | Nadolol | 14 | suppressed |
| Rifabutin | Rifabutin | 14 | suppressed |
| Alogliptin | Alogliptin Benzoate | 13 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 13 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 13 | suppressed |
| Cinacalcet Hcl | Cinacalcet Hcl | 13 | suppressed |
| Exelon | Rivastigmine | 13 | suppressed |
| Haloperidol Decanoate | Haloperidol Decanoate | 13 | suppressed |
| Nystatin-Triamcinolone | Nystatin/Triamcinolone Acet | 13 | suppressed |
| Risperdal Consta | Risperidone Microspheres | 13 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 13 | suppressed |
| Clonidine | Clonidine | 12 | suppressed |
| Insulin Aspart | Insulin Aspart | 12 | suppressed |
| Linzess | Linaclotide | 12 | suppressed |
| Tobramycin-Dexamethasone | Tobramycin/Dexamethasone | 12 | suppressed |
| Viracept | Nelfinavir Mesylate | 12 | suppressed |
| Brimonidine Tartrate-Timolol | Brimonidine Tartrate/Timolol | 11 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 11 | suppressed |
| Fluorouracil | Fluorouracil | 11 | suppressed |
| Kapspargo Sprinkle | Metoprolol Succinate | 11 | suppressed |
| Lapatinib | Lapatinib Ditosylate | 11 | suppressed |
| Levemir | Insulin Detemir | 11 | suppressed |
| Levemir Flexpen | Insulin Detemir | 11 | suppressed |
| Nystop | Nystatin | 11 | suppressed |
| Ondansetron Odt | Ondansetron | 11 | suppressed |
| Polymyxin B Sul-Trimethoprim | Polymyxin B Sulf/Trimethoprim | 11 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 11 | suppressed |
| Verapamil Er | Verapamil Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $328.02 · 6 records | AstraZeneca Pharmaceuticals LP | AUSTEDO XR, Hillrom - Carnation Ambulatory Monitor, LOKELMA, Natroba, PURAPLY WOUND MATRIX, Spinosad | 3 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- How do you evaluate evidence when you have a financial relationship with AstraZeneca Pharmaceuticals LP?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error